California State Teachers Retirement System (CalSTRS)’s Quince Therapeutics QNCX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio QNCX Stock Details QNCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-113	Closed	-$139K	–	3271
2022 Q1	$139K	Sell	113 -12	-10%	-$16.3K	﹤0.01%	2775
2021 Q4	$316K	Buy	125 +4	+3%	+$24.4K	﹤0.01%	2660
2021 Q3	$2.21M	Sell	121 -17	-12%	-$270K	﹤0.01%	1673
2021 Q2	$1.46M	Buy	138 +19	+16%	+$159K	﹤0.01%	1967
2021 Q1	$857K	Hold	119	–	–	﹤0.01%	2237
2020 Q4	$661K	Hold	119	–	–	﹤0.01%	2284
2020 Q3	$1.19M	Hold	119	–	–	﹤0.01%	1774
2020 Q2	$1.1M	Buy	119 +31	+35%	+$284K	﹤0.01%	1811
2020 Q1	$802K	Buy	88 +1	+1%	+$9.87K	﹤0.01%	1802
2019 Q4	$976K	Buy	87 +65	+295%	+$392K	﹤0.01%	1984
2019 Q3	$111K	Hold	22	–	–	﹤0.01%	2922
2019 Q2	$189K	Buy	+22	New	+$131K	﹤0.01%	2867

Other funds holding QNCX

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHAM

Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s QNCX Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Quince Therapeutics (QNCX) in Q2 2022, closing a stake of 113 shares — an estimated $139K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in QNCX in Q2 2019 and held it in 12 quarters. The position peaked at $2.21M in Q3 2021. 66 funds tracked by Wall St. Rank hold QNCX as of Q2 2022.

California State Teachers Retirement System (CalSTRS) reported no remaining Quince Therapeutics position as of Q2 2022 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 113 Quince Therapeutics shares in Q2 2022, an estimated $139K.
California State Teachers Retirement System (CalSTRS) first reported a position in Quince Therapeutics in Q2 2019 and held it in 12 quarters.
California State Teachers Retirement System (CalSTRS)'s Quince Therapeutics position peaked at $2.21M in Q3 2021.
66 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.